Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant

NCT05519397 is registered in ClinicalTrials.gov with Istanbul Training and Research Hospital as lead sponsor.

NCT NCT05519397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05519397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant
Lead sponsor
Istanbul Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
October 1, 2022
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer